APD vs EDIT
Air Products and Chemicals Inc (APD) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
APD currently screens at market cap $62.74B and trailing P/E 29.7. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the APD and EDIT stock pages for the full models.
Not investment advice.